🇺🇸 triazolam tablets in United States

16 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 16

Most-reported reactions

1. Altered State Of Consciousness — 2 reports (12.5%)
2. Dysphagia — 2 reports (12.5%)
3. Head Injury — 2 reports (12.5%)
4. Pleural Fibrosis — 2 reports (12.5%)
5. Pyrexia — 2 reports (12.5%)
6. Renal Failure Acute — 2 reports (12.5%)
7. Abdominal Pain — 1 report (6.25%)
8. Abnormal Behaviour — 1 report (6.25%)
9. Acute Kidney Injury — 1 report (6.25%)
10. Alanine Aminotransferase Increased — 1 report (6.25%)

Source database →

Frequently asked questions

Is triazolam tablets approved in United States?

triazolam tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for triazolam tablets in United States?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.